Navigation Search

SALIENTVALUE


7 Forces Are The Law Of The Land For I/DD Services

By Tom Schramski, PhD, CMAA Volume 4 Issue 7, March 28, 2017 Last Friday, the first edition of Trumpcare bit the dust and Speaker of the House Paul Ryan called Obamacare the “law of the land.” The truth is that neither Obamacare nor Trumpcare rule the landscape of intellectual/development disabilities (I/DD). There are several unique factors…

READ MORE

6 Reasons Why CROs Are Leading The Healthcare Revolution

By Teresa Gonzalo, PhD, MBA, CMAA Volume 4 Issue 6, March 14, 2017 Contract Research Organizations (CROs) positioned themselves as the best performing sector in the healthcare market in 2016 with a thought-provoking and increasingly attractive business model. 2017 looks to be even better. This research and clinical trials sector hit $31.8 billion in 2015 and…

READ MORE

5 Reasons TrumpCare Will Cause A Home Care Boom

By Bradley Smith, ATP, CMAA Volume 4 Issue 5, February 27, 2017 It’s no secret that the home care industry has been in a downward spiral for the past decade, primarily due to declining reimbursements and audits, among other obstacles. As a direct result, the number of providers has decreased, leading to larger and larger companies…

READ MORE

TrumpCare Means “Yuge” Spending On Healthcare IT

By Bradley Smith, ATP, CMAA + Luis de la Prida, MBA, CMAA Volume 4 Issue 4, February 14, 2017 Every sector of the healthcare industry is struggling to figure out what TrumpCare will mean to their businesses. Some will do better under TrumpCare, but most will do worse. There is one sector, however, which is guaranteed…

READ MORE

5 Ways TrumpCare Will Slam I/DD Companies

By Tom Schramski, PhD, CMAA Volume 4 Issue 3, January 31, 2017 The inauguration of President Trump has prompted concern among executives in the intellectually/developmentally disabled (I/DD) marketplace. What’s going to happen next? What should companies do to protect themselves against reimbursement cuts and other potentially catastrophic changes? What’s Going to Happen … Based upon my…

READ MORE

5 Ways To Increase The Financial Value Of A Healthcare Company

By David Coit, Jr., DBA, CVA, CVGA, CMAA Volume 4 Issue 2, January 17, 2017 Owners of healthcare companies are accustomed to creating financial value by focusing on the traditional approaches of scope of services, client/patient capacity, and revenue streams via reimbursement yield and patient volume. While revenue growth and operational efficiency are key value…

READ MORE

11 Reasons That 2017 Will Change Healthcare Forever

By Teresa Gonzalo, PharmD, PhD, MBA, CMAA Volume 4 Issue 1, January 3, 2017 2016 was a transitional year for Life Sciences, Pharma, and Biotech. Worldwide political changes upset long-standing systems that provided stability for the sector. At the same time, disruptive innovation weakened the power of huge companies to dominate these industry sectors. Despite…

READ MORE

7 Ways TrumpCare Will Change The Healthcare Industry

By Tom Schramski, PhD, CMAA Volume 3 Issue 26, December 28, 2016 At this point, only one thing is certain about TrumpCare: it’s going to happen. But what will it look like? At this point nobody knows, probably including even Trump himself. Nevertheless, it’s possible to read some “tea leaves” in Trump’s appointments and the statements…

READ MORE

How To Save Your Addiction Rx Company From The TrumpCare Tsunami

By Tom Schramski, PhD, CMAA Volume 3 Issue 25, December 6, 2016 Going forward into the Trump presidency, one thing is certain: US healthcare insurance will change. HHS Secretary nominee Tom Price is a vehement ObamaCare critic. When he takes the reins we can expect a revamp of both the Affordable Care Act (ACA) and Medicaid.…

READ MORE

The 3 Secrets Of Market Multiples

By David E. Coit, Jr., DBA, CMAA Volume 3 Issue 24, November 22, 2016 Have you ever wondered why two seemingly similar companies sell at significantly different multiples? What are buyers seeing in ostensibly comparable companies that causes sale price differences? The three secrets of market multiples are: 1. Potential Growth Buyers are willing to…

READ MORE